• Exchange: NASDAQ GS
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharmaceuticals


34.4800 USD 0.2500 0.72%

As of 20:10:00 ET on 07/25/2014.

Snapshot for Akorn Inc (AKRX)

Open: 34.3800 Day's Range: 34.2500 - 34.9500 Volume: 549,937
Previous Close: 34.7300 52wk Range: 13.4300 - 37.0790 1-Yr Rtn: +147.88%

Stock Chart for AKRX

No chart data available.
  • AKRX:US 34.4400
  • 1D
  • 1M
  • 1Y
Interactive AKRX Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for AKRX

Current P/E Ratio (ttm) 79.2116
Estimated P/E(12/2014) 41.3926
Relative P/E vs. SPX 4.3778
Earnings Per Share (USD) (ttm) 0.4353
Est. EPS (USD) (12/2014) 0.8330
Est. PEG Ratio 1.3920
Market Cap (M USD) 3,583.22
Shares Outstanding (M) 103.92
30 Day Average Volume 1,160,646
Price/Book (mrq) 12.1662
Price/Sale (ttm) 9.9341
Dividend Indicated Gross Yield -%
Cash Dividend (USD) -
Dividend Ex-Date 08/29/1991
5 Year Dividend Growth -
Next Earnings Announcement 08/05/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for AKRX

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for AKRX

Akorn, Inc. develops, manufactures, and markets ophthalmic and injectable pharmaceutical products. The Company sells various diagnostic and therapeutic pharmaceutical products focused primarily on ophthalmology, anesthesia, antidotes, and rheumatology. Akorn also markets ophthalmic surgical instruments and other supplies, and provides contract manufacturing for third parties.

Rajat Rai "Raj"Chief Executive OfficerTimothy A Dick "Tom"CFO/Investor Relations
Bruce KutinskyChief Operating OfficerMark M SilverbergExec VP: Quality Assurance
More Company Profile & Key Executives for AKRX

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Sponsored Links
sec ||= nil